ErgoPharm Uses Nutraceutix Technologies

ErgoPharm Uses Nutraceutix Technologies

REDMOND, Wash.--Nutraceutix Inc. entered into a supply agreement withErgoPharm to introduce sports and fitness health supplements containingNutraceutix' proprietary molecular dispersion technology (MDT).ErgoPharm will use this technology in its prohormone formulations, includingAndro Stack, Androdiol/NorAndrodiol Stack and Androdiol Heat, all available inDecember.

ErgoPharm will also use Nutraceutix' patented controlled delivery technology(CDT) in its thermogenic product, ErgoLean.

"Nutraceutix' goal is to produce the most technologically advancedproducts on the market, and working together with ErgoPharm, we areaccomplishing that objective," said David Howard, president and chiefexecutive officer of Nutraceutix. For more information, visit www.ergopharm.com.